Atai Beckley N V (ATAI)

Dec 05, 2025

Atai Beckley files prospectus supplement for registered shares after Beckley Psytech acquisition - Investing.com Australia

Dec 05, 2025

Dec 05, 2025

Atai Beckley files prospectus supplement for registered shares after Beckley Psytech acquisition By Investing.com - Investing.com South Africa

Dec 05, 2025

Dec 05, 2025

ATAI Life Sciences Files Prospectus for Share Registration - TipRanks

Dec 05, 2025

Dec 05, 2025

Atai Beckley N.V. Files Prospectus Supplement for Common Shares - TradingView

Dec 05, 2025

Dec 01, 2025

Atai Beckley (ATAI) Stock Analysis Report | Ratings, Financials & Performance - Benzinga

Dec 01, 2025

Nov 28, 2025

ATAIAtai Beckley N.V Short Interest - Finviz

Nov 28, 2025

Nov 28, 2025

ATAI Life Sciences Files Prospectus for Share Resale - MSN

Nov 28, 2025

Nov 27, 2025

atai Life Sciences Reports Second Quarter 2025 Financial Results and Recent Corporate Updates - ADVFN

Nov 27, 2025

Nov 27, 2025

Form 8-KCurrent report - ADVFN

Nov 27, 2025

Nov 27, 2025

AtaiBeckley Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights - ADVFN

Nov 27, 2025

Nov 26, 2025

[Form 4] Atai Beckley N.V. Insider Trading Activity - Stock Titan

Nov 26, 2025

Nov 26, 2025

H.C. Wainwright Maintains Buy on Atai Beckley (ATAI) Following Breakthrough Therapy and Merger Completion - MSN

Nov 26, 2025

Nov 25, 2025

Atai Beckley N.V. (ATAI) latest stock news and headlines - Yahoo Finance UK

Nov 25, 2025

Nov 24, 2025

AtaiBeckley advances BPL-003 toward Phase 3 After Strong Phase 2 Data topline data i - Proactive financial news

Nov 24, 2025

Nov 22, 2025

Atai Beckley NV (NASDAQ:ATAI)Shares, Dividends & News - intelligentinvestor.com.au

Nov 22, 2025

Nov 19, 2025

Enhanced (ATAI) overhauls leadership, appoints new CEO, executive chairman and CFO - Stock Titan

Nov 19, 2025

Nov 18, 2025

Atai Beckley N.V. (ATAI) Receives Buy Rating on BPL-003 Edge against Spravato - MSN

Nov 18, 2025

Nov 16, 2025

Atai Beckley N.V (ATAI) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Nov 16, 2025

Nov 14, 2025

H.C. Wainwright reiterates Buy rating on atai Life Sciences stock By Investing.com - Investing.com Nigeria

Nov 14, 2025

Nov 14, 2025

H.C. Wainwright reiterates Buy rating on atai Life Sciences stock - Investing.com India

Nov 14, 2025

Nov 13, 2025

AtaiBeckley to Participate in the Jefferies Global Healthcare Conference in London - The Manila Times

Nov 13, 2025

Nov 13, 2025

AtaiBeckley (NASDAQ: ATAI) London fireside chat at 11:30 GMT; replay for 90 days - Stock Titan

Nov 13, 2025

Nov 12, 2025

AtaiBeckley advances clinical pipeline, strengthens balance sheet in Q3 - Proactive financial news

Nov 12, 2025

Nov 12, 2025

Atai Beckley Q3 Loss Widens, Revenue Rises; Shares Down Pre-Bell - MarketScreener

Nov 12, 2025

Nov 12, 2025

[8-K] ATAI Life Sciences N.V. Reports Material Event | ATAI SEC FilingForm 8-K - Stock Titan

Nov 12, 2025

Nov 12, 2025

Atai Beckley N.V. Announces Breakthrough Therapy Designation for BPL-003 and Positive Phase 2 Results for Treatment-Resistant Depression - Quiver Quantitative

Nov 12, 2025

Nov 12, 2025

Earnings Flash (ATAI) Atai Beckley N.V. Reports Q3 Revenue $749,000 - MarketScreener

Nov 12, 2025

Nov 12, 2025

Earnings Flash (ATAI) Atai Beckley Posts Q3 Net Loss $0.28 a Share, vs. FactSet Est of $0.11 Loss - MarketScreener

Nov 12, 2025

Nov 12, 2025

AtaiBeckley (NASDAQ: ATAI) closes approx. $150M offering, funding into 2029 - Stock Titan

Nov 12, 2025

Nov 11, 2025

AtaiBeckley’s BPL-003 could redefine psychedelics dosing, analysts believe - Proactive Investors

Nov 11, 2025

Nov 10, 2025

Atai Beckley N.V. (ATAI) Discusses BPL-003 Phase IIb Open-Label Extension Study Results in Treatment Resistant DepressionSlideshow (NASDAQ:ATAI) 2025-11-10 - Seeking Alpha

Nov 10, 2025

Nov 10, 2025

Atai Beckley Reports Positive Phase 2b Extension Data for Depression Treatment - MarketScreener

Nov 10, 2025

Nov 10, 2025

Why Atai Life Sciences N.V. (9VC) stock stays undervalued2025 Earnings Impact & Precise Swing Trade Alerts - newser.com

Nov 10, 2025

Nov 10, 2025

Why Atai Life Sciences N.V. (9VC) stock appears on watchlistsPortfolio Performance Report & Low Drawdown Investment Strategies - newser.com

Nov 10, 2025

Nov 10, 2025

AtaiBeckley Announces Positive Topline Data from the Phase - GlobeNewswire

Nov 10, 2025

Nov 10, 2025

Why Atai Life Sciences N.V. (9VC) stock is trending on social media2025 EndofYear Setup & Intraday High Probability Alerts - newser.com

Nov 10, 2025

Nov 10, 2025

Will Atai Life Sciences N.V. (9VC) stock justify high valuationWeekly Gains Report & Fast Exit Strategy with Risk Control - newser.com

Nov 10, 2025

Nov 10, 2025

Is Atai Life Sciences N.V. stock poised for growth2025 Earnings Impact & Weekly Market Pulse Updates - newser.com

Nov 10, 2025

Nov 09, 2025

Is Atai Life Sciences N.V. (9VC) stock nearing a technical breakoutJuly 2025 Macro Moves & Daily Growth Stock Tips - newser.com

Nov 09, 2025

Nov 09, 2025

Will Atai Life Sciences N.V. stock reach all time highs in 2025Trade Ideas & Safe Capital Preservation Plans - newser.com

Nov 09, 2025

Nov 08, 2025

ATAI BECKLEY NV Insider Trades - Nasdaq

Nov 08, 2025

Nov 08, 2025

Published on: 2025-11-08 08:57:18 - newser.com

Nov 08, 2025

Nov 08, 2025

Is Atai Life Sciences N.V. (9VC) stock trading at attractive multiplesPortfolio Value Report & Stock Portfolio Risk Control - newser.com

Nov 08, 2025

Nov 07, 2025

[Form 3] ATAI Life Sciences N.V. Initial Statement of Beneficial Ownership - Stock Titan

Nov 07, 2025

Nov 07, 2025

Will Atai Life Sciences N.V. stock sustain high P E ratios2025 Market WrapUp & Fast Momentum Stock Entry Tips - newser.com

Nov 07, 2025

Nov 07, 2025

Atai Beckley N.V.: Target Price Consensus and Analysts Recommendations | ATAI | NL0015000DX5 - marketscreener.com

Nov 07, 2025

Nov 07, 2025

Atai Beckley N.V.: Revenue and Earnings Analysts Forecasts Revisions | ATAI | NL0015000DX5 - MarketScreener

Nov 07, 2025

Nov 06, 2025

[Form 4] ATAI Life Sciences N.V. Insider Trading Activity - Stock Titan

Nov 06, 2025